India’s primary market pipeline continues to remain active, with two companies from distinct sectors moving a step closer to their public listing journeys. Securities and Exchange Board of India has granted its observations to Hindustan Laboratories and RK Steel Manufacturing Company, enabling both firms to proceed with their proposed initial public offerings (IPOs). The regulatory nod, issued on April 27, 2026, marks a key milestone in their capital-raising plans and reflects ongoing momentum in India’s equity markets.
IPO Structure and Offer Details
The two companies have adopted different approaches in structuring their IPOs, reflecting their individual funding requirements and promoter strategies.
Hindustan Laboratories plans a mixed offering comprising both a fresh issue and an offer for sale (OFS). The company intends to issue 50 lakh new equity shares, while its promoter will offload 91 lakh shares through the OFS route. This combination allows the company to raise fresh capital while also providing an exit opportunity for existing stakeholders.
On the other hand, RK Steel Manufacturing Company has opted for a fully fresh issue model. Its IPO will consist of up to 2 crore equity shares, with no component of promoter stake sale. This indicates that the entire proceeds raised from the offering will flow directly into the company for its operational and financial requirements.
Deployment of IPO Proceeds
The utilisation of funds raised through these IPOs highlights the differing priorities and business models of the two firms.
Hindustan Laboratories, which operates in the pharmaceutical segment, plans to allocate the proceeds primarily towards working capital needs and general corporate purposes. The company focuses on manufacturing generic medicines and has built its presence through a business-to-government (B2G) model, supplying to public healthcare institutions. Strengthening working capital is critical for such a model, given the scale of procurement cycles and supply commitments.
In contrast, RK Steel Manufacturing Company aims to use the funds to reduce its existing debt burden through repayment or prepayment of borrowings. Additionally, a portion of the proceeds will be directed towards working capital requirements and general corporate expenses. The company is engaged in producing steel tubes and pipes, a segment that is closely linked to infrastructure development and industrial demand.
Sectoral Representation and Market Context
The entry of these two companies into the IPO pipeline reflects the diversity of sectors tapping into public markets. The pharmaceutical industry continues to witness steady demand, driven by healthcare expansion and government procurement programmes. Meanwhile, the steel and metal sector remains closely aligned with India’s infrastructure growth trajectory, benefiting from ongoing investments in construction, manufacturing, and urban development.
The timing of these IPO approvals is also notable, as India’s primary market has seen phases of both strong activity and moderation in recent quarters. Companies are increasingly leveraging IPOs not just for expansion, but also for balance sheet strengthening and operational stability.
Regulatory Process and Next Steps
Receiving observations from SEBI is a crucial step in the IPO process, indicating that the regulator has reviewed the draft offer documents. Following this approval, companies can proceed with finalising issue details such as pricing, timelines, and marketing of the offering.
Both Hindustan Laboratories and RK Steel Manufacturing are expected to move ahead with their IPO launches in line with market conditions and internal readiness. Their public offerings will add to the growing list of companies seeking to access capital markets for funding growth and restructuring plans.
Summary
Hindustan Laboratories and RK Steel Manufacturing Company have received regulatory clearance from SEBI to proceed with their IPO plans, marking a significant development in India’s primary market landscape. While Hindustan Laboratories will launch a combined offering of fresh shares and promoter stake sale, RK Steel Manufacturing will issue entirely new shares to raise capital. The funds raised will support working capital needs, debt reduction, and general corporate purposes, depending on the company. Representing the pharmaceutical and steel sectors respectively, both firms highlight the continued sectoral diversity in IPO activity. Their upcoming public issues reflect the broader trend of companies turning to equity markets for expansion, financial restructuring, and long-term growth positioning.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.
